APGE Stock Analysis: Buy, Sell, or Hold?
APGE - Apogee Therapeutics, Inc. Common Stock
$68.89
3.26 (4.97%)
▲
5d:
-4.82%
30d:
-9.09%
90d:
+21.74%
BUY
HIGH Confidence
Last Updated: February 3, 2026
Earnings: Mar 02, 2026
25d
Smart Money Accumulation
APGE is down 7.8% this week, but smart money is accumulating calls. Top strike: $50 2026-04-17 with 2,360 OI. Call ratio: 97% View Scanner →
Strength: 8.6/10
Get Alerted When APGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called APGE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: APGE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: APGE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: APGE is currently trading at $68.89, which is considered oversold relative to its 30-day fair value range of $72.36 to $80.68.
Technical Outlook: Technically, APGE is in a strong uptrend. Immediate support is located at $62.41, while resistance sits at $82.00. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $104.29 (+51.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, APGE is in a strong uptrend. Immediate support is located at $62.41, while resistance sits at $82.00. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $104.29 (+51.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$72.36 -
$80.68
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 51.4% below Wall St target ($104.29)
Fair Price Analysis
30-Day Fair Range
$72.36 -
$80.68
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$62.41
Resistance Level
$82.00
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-14.11
Wall Street Target
$104.29
(+51.4%)
Last updated: February 04, 2026 5:33 AM ET
Data refreshes hourly during market hours. Next update: 6:33 AM
Data refreshes hourly during market hours. Next update: 6:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Carl Dambkowski
SELL
5110 shares
2025-10-01
Carl Dambkowski
SELL
2725 shares
2025-09-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 58 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$277 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 54 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
Advanced APGE Option Strategies
Professional options setups generated by AI based on today's APGE price and gamma walls.
